Study of TCP-ATRA for Adult Patients With AML and MDS
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Leukemia
Related studies linked through entity extraction aliases.
A Study of Imatinib and Nilotinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase
- Status
- COMPLETED
- Phase
- PHASE3
MSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Physical Conditioning and Decitabine for Newly Diagnosed AML Patients Age ≥ 60
- Status
- TERMINATED
- Phase
- PHASE1
An Open-Label, Phase I/II Study of Nilotinib (Tasigna) and MEK-162 (ARRY-162) Used in Combination for Patients With Refractory or Advanced Chronic Myeloid Leukemia and Philadelphia Positive Acute Leukemia (Protocol CAMN107AUS41T)
- Status
- TERMINATED
- Phase
- PHASE1
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib Plus 5-Azacitidine Initial Therapy of Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MS) With FLT3-ITD Mutation
- Status
- COMPLETED
- Phase
- PHASE2
Autologous ROR1R-CAR-T Cells for Chronic Lymphocytic Leukemia (CLL)
- Status
- WITHDRAWN
- Phase
- PHASE1
Pre and Post Treatment Metabolomic Analysis of Leukemia: A Translational Clinical Trial of the Brown Cancer Center
- Status
- WITHDRAWN
- Phase
- N/A
Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
Interferon α for the Therapy of Minimal Residual Disease
- Status
- UNKNOWN
- Phase
- NA
Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source
- Status
- COMPLETED
- Phase
- PHASE1
Omacetaxine in Patients With Intermediate-1 and Higher Risk Myelodysplastic Syndrome (MDS) Post Hypomethylating Agent (HMA) Failure
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase 1 Dose Escalation and Expanded Cohort Study of EPZ-5676 in the Treatment of Pediatric Patients With Relapsed/Refractory Leukemias Bearing a Rearrangement of the MLL Gene
- Status
- COMPLETED
- Phase
- PHASE1
Omacetaxine and Decitabine in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS)
- Status
- TERMINATED
- Phase
- PHASE1
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
- Status
- COMPLETED
- Phase
- NA